Jerome Benedict Durso has bought ALT on 4 days since Dec 2025

Jerome Benedict Durso is a seasoned biopharmaceutical executive who serves as President, Chief Executive Officer, and Chairman of Altimmune, Inc., a biotechnology company headquartered in Gaithersburg, Maryland( Durso, age 57, was appointed to the CEO position in January 2026 and brings extensive industry experience to the role( Prior to his appointment as CEO, he served as an Independent Director at Altimmune and held the position of Chief Operating Officer at Intercept Pharmaceuticals Inc., demonstrating his deep expertise in pharmaceutical operations and corporate leadership(

At Altimmune, Durso oversees a company of 59 employees focused on developing immunotherapeutic products, including HepTcell for hepatitis B treatment and pemvidutide for metabolic dysfunction-associated steatohepatitis (MASH)( As of early 2026, Durso directly owns approximately 0.01% of Altimmune's shares, with a stake valued at approximately $53,900( His appointment to Altimmune's leadership reflects the company's strategic focus on advancing innovative therapeutic candidates through clinical development(

Written by Perplexity from public sources.